Delota Corp. and Parkdale Community Food Bank Form CSR Partnership
Vaughan, Ontario--(Newsfile Corp. - July 26, 2023) - Delota Corp. (CSE: LOTA) ("Delota" or the "Company") spearheads the smoke-free revolution...
News
CPSI to Webcast Its Second Quarter 2023 Conference Call
MOBILE, Ala.--(BUSINESS WIRE)--CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that it will release its financial results for the...
Wolters Kluwer awarded highest client satisfaction award from Black Book Research
Sentri7 and Simplifi+ solutions recognized as top-performing hospital techWALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced that the Sentri7® clinical surveillance...
Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology
REDWOOD CITY, CA / ACCESSWIRE / July 26, 2023 / The integration of AI technology in healthcare has revolutionized the...
CBD of Denver Files to Change Name and Symbol Change to Berliner Innovation and Provide Additional Corporate Updates
Denver, Colorado--(Newsfile Corp. - July 26, 2023) - CBD of Denver (OTC Pink: CBDD) today announced that it has filed...
Philips Named to the Forbes Best Employers for Women 2023 List
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company earned...
Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Canalevia®-CA1 is currently FDA conditionally approved for treatment of CID in dogs and is the first and only treatment for...
CLS Holdings USA, Inc. Discusses Growth Strategy and Significant Debt Reduction with The Stock Day Podcast
PHOENIX, AZ / ACCESSWIRE / July 26, 2023 / The Stock Day Podcast welcomed CLS Holdings USA, Inc. (CLSH) ("the...
AlayaCare Announces Technology Integration with Infusion Ventures
Leading provider of home infusion nursing services in the Northeast selects AlayaCare as its operating systemTORONTO, ON / ACCESSWIRE /...
G1 Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 2, 2023
RESEARCH TRIANGLE PARK, N.C., July 26, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will...
Lumos Pharma to Report Second Quarter 2023 Financial Results and Host Conference Call on August 9, 2023
AUSTIN, Texas, July 26, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate...
Healthcare Triangle Ransomware Protection and Prevention Initiative Draws Initial Support from Multiple Health System Clients
Company offers critical resources for seven key tenets of ransomware cybersecurity: education, assessment, preparedness, protection, detection, response, and recoveryPLEASANTON, Calif.,...
Yield10 Bioscience Files Request for Regulatory Status Review under USDA-APHIS’s SECURE Rule Covering Elite Camelina Designed to Produce the EPA Component of Omega-3 Oil
Camelina containing the omega-3 EPA trait Camelina containing the omega-3 EPA trait growing at acre-scale in the U.S. in spring...
Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ETSOUTH SAN FRANCISCO, Calif., July 26, 2023 (GLOBE NEWSWIRE) --...
Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023
Live Conference Call and Webcast at 8:30 a.m. ETPRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX),...
LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis
SHANGHAI, China and PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- LianBio’s (Nasdaq: LIAN) partner, Tarsus Pharmaceuticals (Tarsus), announced yesterday...
Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government Agencies
HOUSTON, July 26, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced the formation...
ABVC Signs Term Sheet to Acquire Real Estate Assets for Strategic Investments
FREMONT, CA, July 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical...
CorMedix Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 8, 2023
BERKELEY HEIGHTS, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...